<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Leal Reis I</submitter><funding>Fundação para a Ciência e Tecnologia</funding><funding>Prémios Santa Casa Neurociências</funding><pagination>370</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10854557</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(3)</volume><pubmed_abstract>Horses are high-performance athletes prone to sportive injuries such as tendonitis and desmitis. The formation of fibrous tissue in tendon repair remains a challenge to overcome. This impels regenerative medicine to develop innovative therapies that enhance regeneration, retrieving original tissue properties. Multipotent Mesenchymal Stem/Stromal Cells (MSCs) have been successfully used to develop therapeutic products, as they secrete a variety of bioactive molecules that play a pivotal role in tissue regeneration. These factors are released in culture media for producing a conditioned medium (CM). The aforementioned assumptions led to the formulation of equine synovial membrane MSCs (eSM-MSCs)-the cellular pool that naturally regenerates joint tissue-combined with a medium enriched in immu</pubmed_abstract><journal>Animals : an open access journal from MDPI</journal><pubmed_title>Treatment of Equine Tarsus Long Medial Collateral Ligament Desmitis with Allogenic Synovial Membrane Mesenchymal Stem/Stromal Cells Enhanced by Umbilical Cord Mesenchymal Stem/Stromal Cell-Derived Conditioned Medium: Proof of Concept.</pubmed_title><pmcid>PMC10854557</pmcid><funding_grant_id>2023.00246.BD</funding_grant_id><funding_grant_id>2021.05265.BD</funding_grant_id><funding_grant_id>UIDB/00211/2020</funding_grant_id><funding_grant_id>SFRH/BD/146689/2019</funding_grant_id><funding_grant_id>2022.04501.PTDC</funding_grant_id><funding_grant_id>MC-04/17; MC-18-2021</funding_grant_id><pubmed_authors>Lopes B</pubmed_authors><pubmed_authors>Sousa P</pubmed_authors><pubmed_authors>Leal Reis I</pubmed_authors><pubmed_authors>Briote I</pubmed_authors><pubmed_authors>Sousa AC</pubmed_authors><pubmed_authors>Rema A</pubmed_authors><pubmed_authors>Caseiro AR</pubmed_authors><pubmed_authors>Mauricio AC</pubmed_authors><pubmed_authors>Branquinho MV</pubmed_authors><pubmed_authors>Mendonca CM</pubmed_authors><pubmed_authors>Santos JM</pubmed_authors><pubmed_authors>Atayde LM</pubmed_authors><pubmed_authors>Alvites RD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Treatment of Equine Tarsus Long Medial Collateral Ligament Desmitis with Allogenic Synovial Membrane Mesenchymal Stem/Stromal Cells Enhanced by Umbilical Cord Mesenchymal Stem/Stromal Cell-Derived Conditioned Medium: Proof of Concept.</name><description>Horses are high-performance athletes prone to sportive injuries such as tendonitis and desmitis. The formation of fibrous tissue in tendon repair remains a challenge to overcome. This impels regenerative medicine to develop innovative therapies that enhance regeneration, retrieving original tissue properties. Multipotent Mesenchymal Stem/Stromal Cells (MSCs) have been successfully used to develop therapeutic products, as they secrete a variety of bioactive molecules that play a pivotal role in tissue regeneration. These factors are released in culture media for producing a conditioned medium (CM). The aforementioned assumptions led to the formulation of equine synovial membrane MSCs (eSM-MSCs)-the cellular pool that naturally regenerates joint tissue-combined with a medium enriched in immu</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2025-04-05T14:51:17.416Z</modification><creation>2025-04-05T14:51:17.416Z</creation></dates><accession>S-EPMC10854557</accession><cross_references><pubmed>38338013</pubmed><doi>10.3390/ani14030370</doi></cross_references></HashMap>